JHS Svendgaard Laboratories Ltd Stock Price Today (NSE: JHS)
Fundamental Score
JHS Svendgaard Laboratories Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
JHS Svendgaard Laboratories Ltd share price today is ₹6.55, down 4.15% on NSE/BSE as of 30 March 2026. JHS Svendgaard Laboratories Ltd (JHS) is a Small-cap company in the Personal Care sector with a market capitalisation of ₹94.41 (Cr). The 52-week high for JHS share price is ₹16.46 and the 52-week low is ₹6.55. The company has a Return on Equity (ROE) of -10.84% and a debt-to-equity ratio of 0.06.
JHS Svendgaard Laboratories Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
JHS Svendgaard Laboratories Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
JHS Svendgaard Laboratories Share Price Analysis: A ROCE Efficiency Perspective
The personal care industry, often perceived as recession-proof due to the constant demand for essential products, faces a hidden challenge: efficient capital allocation. This analysis examines the financial health of JHS Svendgaard Laboratories Ltd, focusing primarily on its Return on Capital Employed (ROCE). Currently, the JHS Svendgaard Laboratories share price stands at ₹11.05. A key metric to consider is the company's negative ROCE of -5.19%, signalling potential inefficiencies in generating profits from its capital investments.
ROCE is a critical indicator of a company's ability to generate profits from its capital base. A negative ROCE suggests that the company is struggling to achieve profitability from its investments, potentially indicating issues with operational efficiency, pricing strategies, or cost management. When we examine JHS Svendgaard Laboratories Ltd, the negative ROCE raises concerns about the long-term sustainability of its business model. This contrasts sharply with sector peers who demonstrate a more efficient use of capital.
Comparing JHS Svendgaard Laboratories Ltd with peers like
Bajaj Consumer Care Ltd highlights the disparity in performance. While both companies operate within the consumer goods sector, Bajaj Consumer Care Ltd. typically exhibits a more robust ROCE, reflecting potentially stronger management quality and more effective capital allocation strategies. The market's willingness to assign Bajaj Consumer Care a PE rating, where JHS Svendgaard Laboratories has none, could be connected to the perception of management quality and future growth prospects.The negative ROCE directly impacts the company's economic moat. A strong moat, or competitive advantage, protects a company's profitability. With a -5.19% ROCE, JHS Svendgaard Laboratories Ltd struggles to demonstrate a sustainable competitive advantage. This makes the business more vulnerable to competitors and market fluctuations. The absence of a positive return on invested capital weakens the company's ability to reinvest in growth and maintain its market position. This analysis is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra, providing a thorough evaluation of JHS Svendgaard Laboratories' financial standing based on publicly available data.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
JHS Svendgaard Laboratories Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of JHS across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Robust Profit Growth (98.06%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Conservative Debt Levels (D/E: 0.06)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (-10.84%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-5.19%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-2.96%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Limited Growth History (-7.94% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-9.23x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-36.74 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 1.57%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
JHS Svendgaard Laboratories Ltd Financial Statements
Comprehensive financial data for JHS Svendgaard Laboratories Ltd including income statement, balance sheet and cash flow
About JHS (JHS Svendgaard Laboratories Ltd)
JHS Svendgaard Laboratories Ltd is a prominent player in the Indian personal care market, specializing in the creation and distribution of a diverse portfolio of oral and dental hy...giene essentials. With a strong focus on innovation and quality, JHS crafts a comprehensive range of products designed to cater to the everyday needs of consumers. Their offerings span from essential toothbrushes and invigorating toothpastes to refreshing mouthwashes, ensuring a complete oral care routine. The company's commitment extends beyond basic hygiene, venturing into specialized products like teeth whitening gels and denture care tablets, showcasing their dedication to addressing specific consumer demands within the oral health sector. Beyond oral care, JHS Svendgaard Laboratories demonstrates its adaptability by extending its expertise to other personal care segments. The company manufactures and markets a range of products including gentle talcum powders, hand sanitizers, and versatile detergents, reflecting a holistic approach to hygiene and well-being. This diversification allows JHS to reach a broader consumer base and establish a stronger foothold in the competitive personal care market. By consistently innovating and expanding its product lines, JHS Svendgaard Laboratories aims to become a trusted household name, synonymous with quality and reliability in personal care solutions. Moreover, JHS Svendgaard Laboratories actively participates in the global market through its export operations, further solidifying its presence and reach. The company's commitment to maintaining international standards of quality and manufacturing allows it to successfully compete in diverse markets. In addition to its own branded products, JHS also offers contract manufacturing services for oral care products, leveraging its state-of-the-art facilities and expertise to support other brands in the industry. This dual approach, combining proprietary products with contract manufacturing, positions JHS Svendgaard Laboratories as a versatile and reliable partner in the personal care sector, driving growth and innovation across the industry.
Company Details
Key Leadership
Corporate Events
JHS Share Price: Frequently Asked Questions
What is the current share price of JHS Svendgaard Laboratories Ltd (JHS)?
As of 30 Mar 2026, 12:02 pm IST, JHS Svendgaard Laboratories Ltd share price is ₹6.55. The JHS stock has a market capitalisation of ₹94.41 (Cr) on NSE/BSE.
Is JHS share price Overvalued or Undervalued?
JHS share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 50.39x. Based on this relative valuation, the JHS Svendgaard Laboratories Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of JHS share price?
The 52-week high of JHS share price is ₹16.46 and the 52-week low is ₹6.55. These values are updated daily from NSE/BSE price data.
What factors affect the JHS Svendgaard Laboratories Ltd share price?
Key factors influencing JHS share price include quarterly earnings growth (Sales Growth: 13.21%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is JHS Svendgaard Laboratories Ltd a good stock for long-term investment?
JHS Svendgaard Laboratories Ltd shows a 5-year Profit Growth of N/A% and an ROE of -10.84%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.06 before investing in JHS shares.
How does JHS Svendgaard Laboratories Ltd compare with its industry peers?
JHS Svendgaard Laboratories Ltd competes with major peers in the Personal Care. Investors should compare JHS share price P/E of 0.00x and ROE of -10.84% against the industry averages to determine competitive standing.
What is the P/E ratio of JHS and what does it mean?
JHS share price has a P/E ratio of N/Ax compared to the industry average of 50.39x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is JHS performing according to Bull Run's analysis?
JHS has a Bull Run fundamental score of 13.3/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does JHS belong to?
JHS operates in the Personal Care industry. This classification helps understand the competitive landscape and sector-specific trends affecting JHS Svendgaard Laboratories Ltd share price.
What is Return on Equity (ROE) and why is it important for JHS?
JHS has an ROE of -10.84%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently JHS Svendgaard Laboratories Ltd generates profits from shareholders capital.
How is JHS debt-to-equity ratio and what does it indicate?
JHS has a debt-to-equity ratio of 0.06, which indicates conservative financing with low financial risk.
What is JHS dividend yield and is it a good dividend stock?
JHS offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in JHS Svendgaard Laboratories Ltd shares.
How has JHS share price grown over the past 5 years?
JHS has achieved 5-year growth rates of: Sales Growth -7.94%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in JHS and why does it matter?
Promoters hold 34.56% of JHS shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in JHS Svendgaard Laboratories Ltd.
What is JHS market capitalisation category?
JHS has a market capitalisation of ₹94 crores, placing it in the Small-cap category.
How volatile is JHS stock?
JHS has a beta of N/A. A beta > 1 suggests the JHS Svendgaard Laboratories Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is JHS operating profit margin trend?
JHS has a 5-year average Operating Profit Margin (OPM) of -2.96%, indicating the company's operational efficiency.
How is JHS quarterly performance?
Recent quarterly performance shows JHS Svendgaard Laboratories Ltd YoY Sales Growth of 13.21% and YoY Profit Growth of 98.06%.
What is the institutional holding pattern in JHS?
JHS has FII holding of 1.57% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the JHS Svendgaard Laboratories Ltd stock.